Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Immunology, Allergology, Rheumatology, Antwerp University Hospital, Antwerp, Belgium.
Front Immunol. 2023 Jan 16;13:1026304. doi: 10.3389/fimmu.2022.1026304. eCollection 2022.
Occupancy of MRGPRX2 heralds a new era in our understandings of immediate drug hypersensitivity reactions (IDHRs), but a constitutive expression of this receptor by basophils is debated.
To explore the expression and functionality of MRGPRX2 in and on basophils.
Basophils from patients with birch pollen allergy, IDHRs to moxifloxacin, and healthy controls were studied in different conditions, that is, in rest, after stimulation with anti-IgE, recombinant major birch pollen allergen (rBet v 1), moxifloxacin, fMLP, substance P (SP), or other potential basophil secretagogues. In a separate set of experiments, basophils were studied after purification and resuspension in different media.
Resting whole blood basophils barely express MRGPRX2 on their surface and are unresponsive to SP or moxifloxacin. However, surface MRGPRX2 is quickly upregulated upon incubation with anti-IgE or fMLP. Pre-stimulation with anti-IgE can induce a synergic effect on basophil degranulation in IgE-responsive subjects after incubation with SP or moxifloxacin, provided that basophils have been obtained from patients who experienced an IDHR to moxifloxacin. Cell purification can trigger a "spontaneous" and functional upregulation of MRGPRX2 on basophils, not seen in whole blood cells, and its surface density can be influenced by distinct culture media.
Basophils barely express MRGPRX2 in resting conditions. However, the receptor can be quickly upregulated after stimulation with anti-IgE, fMLP, or after purification, making cells responsive to MRGPRX2 occupation. We anticipate that such "conditioned" basophils constitute a model to explore MRGPRX2 agonism or antagonism, including IDHRs originating from the occupation of this receptor.
MRGPRX2 的占据标志着我们对即刻药物过敏反应 (IDHR) 理解的新时代,但该受体在嗜碱性粒细胞中的组成性表达存在争议。
探索 MRGPRX2 在嗜碱性粒细胞中的表达和功能。
研究了来自桦树花粉过敏患者、IDHR 对莫西沙星和健康对照者的嗜碱性粒细胞在不同条件下的表达和功能,即在静止状态下,用抗 IgE、重组主要桦树花粉过敏原 (rBet v 1)、莫西沙星、fMLP、P 物质 (SP) 或其他潜在的嗜碱性粒细胞分泌剂刺激后。在另一组实验中,在不同的培养基中分离和重悬后研究了嗜碱性粒细胞。
静止全血嗜碱性粒细胞表面几乎不表达 MRGPRX2,对 SP 或莫西沙星无反应。然而,孵育抗 IgE 或 fMLP 后,表面 MRGPRX2 迅速上调。在 IgE 反应性个体中,用抗 IgE 预先刺激可以在孵育 SP 或莫西沙星后诱导协同作用,前提是嗜碱性粒细胞来自经历莫西沙星 IDHR 的患者。细胞纯化可以触发嗜碱性粒细胞上 MRGPRX2 的“自发”和功能性上调,在全血细胞中未见,其表面密度可受不同的培养介质影响。
在静止状态下,嗜碱性粒细胞几乎不表达 MRGPRX2。然而,用抗 IgE、fMLP 刺激或纯化后,该受体可以快速上调,使细胞对 MRGPRX2 占据敏感。我们预计,这种“调节”的嗜碱性粒细胞构成了一个探索 MRGPRX2 激动剂或拮抗剂的模型,包括源自该受体占据的 IDHR。